Advances in adjuvant hormonal therapy for postmenopausal women
- PMID: 15755983
- DOI: 10.1200/JCO.2005.11.038
Advances in adjuvant hormonal therapy for postmenopausal women
Comment in
-
Optimizing endocrine therapy for breast cancer.J Clin Oncol. 2005 Mar 10;23(8):1609-10. doi: 10.1200/JCO.2005.01.005. J Clin Oncol. 2005. PMID: 15755964 No abstract available.
Similar articles
-
[Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].Ugeskr Laeger. 2007 Jan 22;169(4):297-9. Ugeskr Laeger. 2007. PMID: 17274922 Review. Danish.
-
[Neoadjuvant antihormonal treatment of women with breast cancer].Ugeskr Laeger. 2007 Sep 10;169(37):3077-81. Ugeskr Laeger. 2007. PMID: 17877952 Review. Danish.
-
[Adjuvant treatment of breast cancer. Endocrine therapy].Ugeskr Laeger. 2007 Sep 10;169(37):3072-6. Ugeskr Laeger. 2007. PMID: 17877951 Danish.
-
Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.Oncol Nurs Forum. 2008 Jul;35(4):714-21. doi: 10.1188/08.ONF.714-721. Oncol Nurs Forum. 2008. PMID: 18591176 Review.
-
[Future endocrine therapy of breast cancer].Ugeskr Laeger. 2007 Jan 22;169(4):296. Ugeskr Laeger. 2007. PMID: 17274921 Danish. No abstract available.
Cited by
-
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.Nat Genet. 2013 Dec;45(12):1439-45. doi: 10.1038/ng.2822. Epub 2013 Nov 3. Nat Genet. 2013. PMID: 24185512 Free PMC article.
-
Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer: Physician's Choices.Int J Breast Cancer. 2012;2012:849592. doi: 10.1155/2012/849592. Epub 2012 Dec 9. Int J Breast Cancer. 2012. PMID: 23304528 Free PMC article.
-
Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.PLoS One. 2018 Mar 28;13(3):e0193779. doi: 10.1371/journal.pone.0193779. eCollection 2018. PLoS One. 2018. PMID: 29590154 Free PMC article.
-
Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.Front Endocrinol (Lausanne). 2019 May 24;10:245. doi: 10.3389/fendo.2019.00245. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31178825 Free PMC article. Review.
-
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Int J Mol Sci. 2012 Dec 20;14(1):108-45. doi: 10.3390/ijms14010108. Int J Mol Sci. 2012. PMID: 23344024 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical